Cincinnati, United States
Medpace is a global clinical contract research organization (CRO) that offers Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Founded in 1992, the company's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach. With approximately 5,800 employees across 42 countries, Medpace leverages local regulatory and deep therapeutic expertise in areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, anti-viral, and anti-infective.
Headquartered in Cincinnati, Ohio, Medpace has built a reputation for its scientific rigor and comprehensive service offerings. The company's slogan, "Accelerating Drug, Biologic, and Medical Device Clinical Development," aligns with its commitment to advancing therapeutic development in the biotechnology and pharmaceutical industries. Although specific details about the last investment and investors are not available, Medpace continues to thrive as a prominent player in the clinical research space.
